Polymyalgia rheumatica treatment (Polymyalgia rheumatica (PMR) management)
Treatment, usually with a gradually reducing course of steroid tablets, to relieve the shoulder and hip stiffness of polymyalgia rheumatica while watching for the linked condition giant cell arteritis.
✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review
In short
- PMR is usually treated with a steroid tablet (prednisolone) that often relieves stiffness within days, then is reduced slowly over many months.
- It is closely linked to giant cell arteritis: new headache, scalp tenderness, jaw ache on chewing or any visual symptoms need urgent attention, as sight loss can be permanent.
- Reducing the steroid too quickly can make symptoms return, so the dose is tapered gradually and not stopped suddenly.
- Longer-term steroids carry risks (bones, blood pressure, blood sugar), so bone protection and monitoring are part of treatment.
A plain-English summary. The detail — including risks and recovery — is below.
At a glance
A general guide. Your specialist will give you advice for your situation.
Often relieves shoulder and hip stiffness within days
Steroids need caution and extra monitoring if you have diabetes, uncontrolled high blood pressure, osteoporosis, stomach ulcers or certain infections.
Stiffness and pain often improve quickly once steroids start — a marked response is typical in PMR and supports the diagnosis.
A clear written steroid-reduction plan and a steroid card, with advice never to stop suddenly.
Stiffness and pain often improve quickly once steroids start — a marked response is typical in PMR and supports...
Symptoms are reassessed and the steroid dose is confirmed. Bone protection and monitoring are set up, and you...
The dose is reduced gradually, guided by your symptoms. Some people have a flare of stiffness when the dose is...
Many people are able to reduce and eventually stop steroids over this period, though some need treatment for...
What is polymyalgia rheumatica treatment?
Polymyalgia rheumatica (PMR) is an inflammatory condition that causes pain and stiffness, mainly in the shoulders, neck and hips. The stiffness is typically worst in the morning and can make everyday movements, like dressing or getting out of a chair, difficult. It mostly affects people over 50 and is more common in women.
The main treatment is a steroid tablet, usually prednisolone, started at a moderate dose. PMR usually responds quickly — often within days — which is part of how the diagnosis is supported. The dose is then reduced slowly over many months, guided by symptoms, until it can be stopped.
PMR is closely linked to giant cell arteritis (GCA), a more serious inflammation of larger arteries that can threaten eyesight. Some people with PMR develop GCA, and watching for its warning signs is an essential part of treatment, because GCA needs urgent, higher-dose steroid treatment to protect vision.
Treatment relieves symptoms well in most people, but it is not a quick fix: the steroid course usually lasts a year or two, and reducing it too fast can cause symptoms to return. Managing the side effects of longer-term steroids is an important part of care.
Types, options & approaches
There may be different ways to do this. The right approach depends on the clinical question and your circumstances.
Polymyalgia rheumatica vs giant cell arteritis
| PMR | Giant cell arteritis | |
|---|---|---|
| Main symptoms | Shoulder, neck and hip stiffness | Headache, scalp tenderness, jaw ache, visual symptoms |
| Urgency | Not usually an emergency | Medical emergency — risk to sight |
| Steroid dose | Moderate, reducing | Higher, started urgently |
| Why it matters | Relieves stiffness | Protects eyesight |
The two are linked. Anyone treated for PMR should know the warning signs of giant cell arteritis and seek urgent help if they occur.
Preparing for your treatment
- Describe your stiffness — where it is, how bad it is in the morning, and how it affects daily tasks.
- Bring your current medicines, and mention diabetes, high blood pressure, osteoporosis, stomach ulcers or glaucoma, as steroids can affect these.
- Tell your clinician about any headache, scalp tenderness, jaw ache on chewing or visual symptoms straight away.
- Ask about bone protection, calcium and vitamin D before or as you start steroids.
- Expect blood tests to support the diagnosis and to monitor you during treatment.
- Discuss a steroid card and the importance of not stopping steroids suddenly.
- Ask what dose you are starting on and how it will be reduced over time.
What happens
Your clinician makes the diagnosis from your symptoms, examination and blood tests, and importantly checks for any features of giant cell arteritis. PMR usually responds quickly to steroids, and that response helps confirm the diagnosis.
You are started on a moderate dose of prednisolone, which often eases the stiffness within days. You are given a plan to reduce the dose gradually over many months, along with bone-protecting treatment and advice on the side effects of steroids and the warning signs of giant cell arteritis.
If, instead, features of giant cell arteritis are present, treatment is different and urgent: a higher steroid dose is usually started straight away, often before tests are complete, to protect eyesight. You are then reviewed over time, with the dose adjusted to your symptoms, monitoring for side effects, and a steroid-sparing medicine added if the steroid cannot be reduced smoothly.
Is this treatment right for me?
A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.
May not be suitable if…
- Steroids need caution and extra monitoring if you have diabetes, uncontrolled high blood pressure, osteoporosis, stomach ulcers or certain infections.
- A steroid course is not appropriate without first considering whether the diagnosis could be something else that mimics PMR.
- Steroid-sparing medicines such as methotrexate are not suitable for everyone and need their own checks.
- PMR treatment does not replace urgent treatment for giant cell arteritis, which needs higher-dose steroids straight away.
Delay or rearrange if…
- Features of giant cell arteritis are present — treatment should not be delayed; urgent, higher-dose steroids are usually needed instead.
- An active infection needs treating and may affect steroid use.
- The diagnosis is uncertain and a quick response to steroids could mask another condition that needs different treatment.
- Bone protection has not been considered in someone at high risk of fractures.
Alternatives to discuss
- Reviewing the diagnosis if the response to steroids is poor or atypical.
- Adding a steroid-sparing medicine to reduce the steroid dose where side effects or flares are a problem.
- Simple pain relief as a temporary measure while the diagnosis is being confirmed (it does not treat the underlying condition).
- Referral to a rheumatologist for difficult or relapsing disease.
Before you decide
Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.
What matters most to me?
Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.
What are all my options?
Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.
What would make me pause?
Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.
What happens if I do nothing today?
For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.
Benefits
- Often relieves shoulder and hip stiffness within days
- Restores everyday movement and quality of life
- Helps confirm the diagnosis through a clear response
- Allows the dose to be reduced to the lowest needed over time
- Provides a framework to watch for and act on giant cell arteritis
Risks & complications
- Steroid side effects such as weight gain, increased appetite, mood changes and disturbed sleep
- Raised blood sugar and blood pressure, especially at higher doses
- Symptoms returning if the dose is reduced too quickly
- The need for regular reviews and blood tests during treatment
- Bone thinning (osteoporosis) with longer-term steroids, which protection aims to reduce
- Indigestion or stomach problems
- Needing a steroid-sparing medicine such as methotrexate if the steroid cannot be reduced
- Developing giant cell arteritis, which can threaten eyesight and needs urgent treatment
- Serious infections while on steroids
- Other significant steroid complications with prolonged or high-dose use
Two things matter most in PMR. First, never stop steroids suddenly — the dose must be reduced gradually, and a steroid card helps others know you are taking them. Second, watch for giant cell arteritis: a new or severe headache, tenderness of the scalp or temples, jaw ache when chewing, or any visual symptoms need urgent medical attention, because sight loss can be permanent. Longer-term steroids also need bone protection and monitoring of blood pressure and blood sugar.
Published figures to discuss
PMR usually responds well to steroids, but how long treatment is needed and whether symptoms return varies between people. The most important risk is the linked condition giant cell arteritis, where untreated disease can cause permanent sight loss — this is why warning signs are taken seriously and treated urgently. Longer-term steroids also carry well-recognised side effects that monitoring aims to reduce.
| Figure | Reported range | How to interpret it | Source / confidence |
|---|---|---|---|
| Permanent sight loss in untreated giant cell arteritis | Reported in up to around 1 in 5 people if untreated | Based on NHS information; relevant because PMR is linked to giant cell arteritis. Sight loss is usually irreversible, so visual symptoms are an emergency. | NHS — Polymyalgia rheumaticanhs.ukPublished figure |
| Giant cell arteritis occurring with polymyalgia rheumatica | Often quoted around 10 to 20% over the disease course | New headache, scalp tenderness, jaw pain when chewing or visual symptoms need same-day assessment. | NHS — Polymyalgia rheumaticanhs.ukPublished figure |
| Relapse while reducing steroids | Common; many series report relapse in roughly one-third to one-half of patients | Relapse usually means the taper needs review; repeated relapse should prompt reconsideration of diagnosis and steroid-sparing options. | Guide sourcesClinical context |
| Steroid adverse effects during PMR treatment | Common because treatment often lasts many months to years | Bone protection, blood pressure, glucose, weight, eye and infection risk should be actively managed. | NHS — Polymyalgia rheumaticanhs.ukSource-linked context |
These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.
What happens afterwards
There is no physical recovery from the treatment itself. The key is the response: stiffness often improves within days of starting steroids, but the treatment course itself usually lasts many months as the dose is slowly reduced.
- A quick, often dramatic improvement in stiffness when steroids start
- Some return of stiffness when the dose is reduced, sometimes needing a slower taper
- Steroid side effects that are more noticeable at higher doses early on
- A treatment course lasting many months rather than weeks
Aftercare
- Take steroids exactly as prescribed and never stop them suddenly — follow the reduction plan.
- Carry a steroid card and tell any healthcare professional that you are taking steroids.
- Keep up bone-protecting treatment, calcium and vitamin D as advised.
- Attend reviews and blood tests so the dose, side effects and any flare can be managed.
- Watch for and report new headache, scalp tenderness, jaw ache on chewing or any visual symptoms urgently.
- Report symptoms returning as the dose is reduced, so the taper can be adjusted.
- Watch for signs of infection or high blood sugar (such as increased thirst) and report them.
- A written steroid plan showing the dose and how it reduces
- A steroid card to carry
- Bone protection, calcium and vitamin D arranged
- Your next review and blood tests booked
- Knowing the warning signs of giant cell arteritis
- A contact route for advice if symptoms return or visual symptoms occur
⚠ Get urgent help if…
- Sudden loss of vision, blurring or double vision in one or both eyes — a medical emergency, seek help immediately
- A new or severe headache, or tenderness of the scalp or temples
- Jaw ache or tiredness in the jaw when chewing
- Symptoms suggesting infection while on steroids: fever, feeling very unwell
- A marked return of stiffness and pain as the steroid is reduced
- Symptoms of high blood sugar, such as increased thirst, tiredness and passing more urine
Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.
General guidance — it doesn't replace the specific advice your specialist gives you.
Results & realistic expectations
A good result is relief of the shoulder and hip stiffness, return to normal daily activities, and a steroid dose that can be reduced over time to the lowest needed and eventually stopped — all while avoiding the complications of giant cell arteritis.
The quick response to steroids is reassuring and helps confirm the diagnosis, but it is not a cure: PMR runs its course over time, and the aim is to control symptoms safely until it settles. A poor or unusual response may prompt a rethink of the diagnosis.
PMR usually settles over time, and many people are able to stop steroids after one to two years, although some need treatment for longer and a minority have symptoms that return after stopping. Because of this, the treatment plan is reviewed as the condition evolves, and any return of symptoms is reassessed rather than simply treated with more steroids indefinitely.
Related tests, treatments or support
PMR treatment is managed alongside the side effects of steroids — bone health, blood pressure and blood sugar — and alongside vigilance for giant cell arteritis. If giant cell arteritis develops, care often involves additional specialists, including an ophthalmologist if eyesight is threatened.
Follow-up & long-term care
You will be reviewed regularly to adjust the steroid dose, check your response and watch for side effects, with blood tests during treatment. Reviews are more frequent early on and around dose reductions. Any return of symptoms, or features of giant cell arteritis, prompts earlier assessment.
- A gradually reducing steroid course, not stopped suddenly
- Bone protection, calcium and vitamin D during steroid treatment
- Regular monitoring of blood pressure and blood sugar
- Ongoing vigilance for giant cell arteritis warning signs
- Review of any symptom return after the steroid is reduced or stopped
Repeat, follow-on and what comes next
- The steroid dose is adjusted up and down over time, guided by symptoms, rather than following a fixed schedule.
- Some people flare when the dose is reduced and need a slower taper or a steroid-sparing medicine.
- If the response is poor or unusual, the diagnosis may be revisited.
Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.
What good aftercare looks like
- A clear written steroid-reduction plan and a steroid card, with advice never to stop suddenly.
- Bone protection, calcium and vitamin D, and monitoring of blood pressure and blood sugar.
- Clear, written warning signs for giant cell arteritis and an urgent contact route for visual symptoms.
- Regular review to adjust the dose, manage flares and reconsider the diagnosis if needed.
What affects the cost
Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:
- Whether you see a GP or a private rheumatologist, and how many follow-up appointments are needed
- Blood tests to support diagnosis and to monitor treatment over time
- Bone protection treatment, calcium and vitamin D, and bone density scanning if needed
- Any steroid-sparing medicine, such as methotrexate, and its monitoring
- Urgent assessment and additional tests if giant cell arteritis is suspected
- The length of the steroid course and the reviews needed to taper it safely
- The consultation fee and the expected number of follow-up visits
- The cost and frequency of monitoring blood tests
- Whether bone protection and any bone density scan are included
- The cost of any steroid-sparing medicine and its monitoring
- What happens, and what it costs, if giant cell arteritis is suspected and needs urgent care
- Whether prescriptions are issued for you to dispense through a community pharmacy
On the NHS? PMR is commonly diagnosed and managed on the NHS, often by a GP, with rheumatology referral when the diagnosis is unclear or treatment is difficult; private care is mainly used for faster access or a specialist opinion.
You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.
Consent traps and marketing red flags
These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.
Consent traps
- Not being warned never to stop steroids suddenly, or not being given a steroid card.
- No clear advice on the warning signs of giant cell arteritis and the need for urgent help.
- Bone protection and monitoring not arranged for a months-long steroid course.
- Assuming a quick response confirms PMR without considering other conditions that can mimic it.
Marketing red flags
- Claims of a 'cure' for PMR or that a supplement can replace steroids.
- Long-term steroid treatment offered without bone protection or monitoring.
- Downplaying the link to giant cell arteritis and the risk to eyesight.
- Promising a fixed, short course when PMR often needs many months of carefully reduced treatment.
Choosing a specialist safely
- Check the specialist is on the GMC Specialist Register for this area.
- Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
- You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
- Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
- You're entitled to your total cost in writing — including any follow-up — before you decide.
Questions to ask your medical professional
Take this to your consultation. A good specialist will welcome every one of these.
- What dose of steroid am I starting on, and how will it be reduced?
- What bone protection and monitoring do I need while on steroids?
- What are the warning signs of giant cell arteritis, and what should I do?
- What should I do if my stiffness returns as the dose is lowered?
- Might I need a steroid-sparing medicine such as methotrexate?
- How long are you expecting my treatment to last?
- Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
- Will you be the specialist who carries out my treatment, and who looks after me afterwards?
- What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
- What does a realistic result look like — and what can this treatment not achieve?
- What are my options, including waiting, doing nothing for now, or choosing a different approach?
- Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
- What is the total cost in writing, including any follow-ups, and how much time do I have to decide?
Frequently asked questions
Can polymyalgia rheumatica be treated on the NHS?
How quickly will the steroids work?
How long will I need to take steroids?
What is giant cell arteritis and why does it matter?
Why can't I just stop the steroids when I feel better?
What can I do about steroid side effects?
Find a verified specialist for polymyalgia rheumatica treatment
Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.
No verified consultants list this procedure yet — browse the full directory.
How we made this page
Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →
Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.
Sources & standards: NHS — Polymyalgia rheumatica NHS — Temporal arteritis (giant cell arteritis) Versus Arthritis — Polymyalgia rheumatica (PMR) Versus Arthritis — Giant cell arteritis (GCA) PMRGCAuk — patient support and information British Society for Rheumatology — Polymyalgia rheumatica guideline
Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.
Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.
Related guides: Vasculitis treatment · Lupus (SLE) treatment · Ankylosing spondylitis / axial SpA treatment and management · Disease-modifying drugs (DMARDs) · Fibromyalgia treatment